Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union

Given as an Injection Every Six Months, Prolia Reduced the Risk of Fractures in Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fractures

THOUSAND OAKS, California, May 28, 2010 – Amgen Inc. (Nasdaq: AMGN) today announced that the European Commission
(EC) has granted marketing authorization for Prolia(R) (denosumab) for the
treatment of osteoporosis in postmenopausal [...]

FirstAidWarehouse.co.uk Examines High Blood Pressure, or Hypertension, and Blood Pressure Monitors

YORK, England, May 28, 2010 – High blood pressure is a leading cause of deaths in the world. Apart from
millions with diagnosed hypertension, still many others are borderline
hypertensive. High blood pressure increases the risk of a person to develop
cardiovascular diseases, kidney problems, heart attack and even a stroke. One
of the major contributors to high [...]